Safety and efficacy of pleurodesis with thoracoscopic doxycycline poudrage in malignant pleural effusion Source: Annual Congress 2011 - Molecular markers: diagnosis and management of malignant pleural effusions Year: 2011
Thoracoscopic talc pleurodesis in malignant pleural effusions Source: Eur Respir J 2005; 26: Suppl. 49, 72s Year: 2005
Thoracoscopic talc pleurodesis in malignant pleural effusions Source: Eur Respir J 2005; 26: Suppl. 49, 172s Year: 2005
Efficacy and safety of talc pleurodesis in patients with malignant pleural effusions Source: Eur Respir J 2006; 28: Suppl. 50, 754s Year: 2006
Efficacy of talc pleurodesis in patients with malignant pleural effusions Source: Annual Congress 2011 - Molecular markers: diagnosis and management of malignant pleural effusions Year: 2011
Thoracoscopic tetracycline poudrage for pleurodesis in malignant pleural effusion Source: International Congress 2016 – Pleural diseases Year: 2016
Thoracoscopic talc poudrage versus povidone-iodine for pleurodesis of effusion due to metastatic breast cancer Source: Eur Respir J 2006; 28: Suppl. 50, 754s Year: 2006
Audit of success rate and complications of talc slurry pleurodesis for malignant pleural effusions Source: Annual Congress 2008 - Pleural diseases and interventions Year: 2008
Efficacy of rapid pleurodesis in malignat pleural effusions Source: Annual Congress 2010 - Clinical diagnosis and management of malignant pleural effusions Year: 2010
Therapeutic local procedures: pleurodesis Source: ISSN=1025-448x, ISBN=1-904097-25-1, page=311 Year: 2002
Thoracoscopic pleurodesis for malignant pleural effusion Source: ERS Skills Course 2015 Year: 2015
Thoracoscopic talc poudrage induces T-lymphopenia Source: Annual Congress 2005 - What's new in the pleura Year: 2005
Predictors of successful pleurodesis for patients with malignant pleural effusions Source: Eur Respir J 2004; 24: Suppl. 48, 493s Year: 2004
Talc pleurodesis in malignant pleural effusions: A 5-year experience Source: Annual Congress 2012 - Medical access to the pleura Year: 2012
Talc pleurodesis in malignant pleural effusions Source: Eur Respir J 2001; 18: Suppl. 33, 386s Year: 2001
Life expectancy of patients with malignant pleural effusion treated by video-assisted thoracoscopic talc pleurodesis Source: Eur Respir J 2004; 24: Suppl. 48, 628s Year: 2004
Long-term follow-up of thoracoscopic talc pleurodesis for primary spontaneous pneumothorax Source: Eur Respir J 2007; 29: 757-760 Year: 2007
Videothoracoscopy is effective for the management of pneumothorax recurrences after talc pleurodesis Source: Eur Respir J 2003; 22: Suppl. 45, 369s Year: 2003
Diagnostic thoracoscopy in suspected malignant disease of the pleura: Pleural nodularity justifies talc poudrage Source: Annual Congress 2011 - Molecular markers: diagnosis and management of malignant pleural effusions Year: 2011
Thoracoscopic evaluation of the effect of tumour burden on the outcome of pleurodesis in malignant pleural effusion Source: Virtual Congress 2021 – Pleural disease and bronchoscopic lung volume reduction Year: 2021